0366 : Prevalence of the metabolic syndrome in psoriasis patients: morroccan experience

Background Psoriasis is a chronic inflammatory disease associated with multiple comorbidities that are components of the metabolic syndrome (MS). Several studies have objectified a high prevalence of MS in psoriasis patients. Objective To determine the prevalence of MS and its components in psoriasis patients compared with controls, also the factors determinants the occurrence of MS in our patients. Patients and Methods This was a prospective study including 100 psoriasis patients versus 100 controls seen in consultation or in hospitals. Conducted for a period of 12 months. Results The prevalence of MS was higher in patients with psoriasis compared with controls (OR=2.89, p=0,0002). With a significant increase in obesity (OR=3.25, p=0.001), hypertriglyceridemia (OR=3.9, p=0.013) and glucose intolerance (OR = 2.13, p = 0.046). Risk factors determining the appearance of SM in psoriatic were age, family history of psoriasis, seniority of psoriasis, but we did not find a correlation with sex, severity of psoriasis and the clinical form. Conclusion The management of psoriasis will integrate research risk factors for a possible metabolic syndrome and its treatment through a multidisciplinary approach.